As of 2024-12-14, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (34.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.61 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -233.1%.
The range of the Relative Valuation is (15.63) - (50.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 17.5x | 11.4x |
| Forward P/E multiples | 5.4x - 18.8x | 12.1x |
| Fair Price | (15.63) - (50.64) | (34.08) |
| Upside | -161.0% - -297.7% | -233.1% |
| Date | P/E |
| 2024-11-29 | -10.58 |
| 2024-11-27 | -10.76 |
| 2024-11-26 | -10.10 |
| 2024-11-25 | -10.18 |
| 2024-11-22 | -10.26 |
| 2024-11-21 | -10.27 |
| 2024-11-20 | -10.36 |
| 2024-11-19 | -10.26 |
| 2024-11-18 | -10.14 |
| 2024-11-15 | -9.81 |
| 2024-11-14 | -10.47 |
| 2024-11-13 | -11.79 |
| 2024-11-12 | -10.14 |
| 2024-11-11 | -9.72 |
| 2024-11-08 | -9.84 |
| 2024-11-07 | -10.11 |
| 2024-11-06 | -10.30 |
| 2024-11-05 | -9.89 |
| 2024-11-04 | -9.94 |
| 2024-11-01 | -9.93 |
| 2024-10-31 | -9.97 |
| 2024-10-30 | -10.09 |
| 2024-10-29 | -10.44 |
| 2024-10-28 | -10.64 |
| 2024-10-25 | -10.62 |
| 2024-10-24 | -10.75 |
| 2024-10-23 | -11.18 |
| 2024-10-22 | -11.54 |
| 2024-10-21 | -11.57 |
| 2024-10-18 | -12.18 |
| 2024-10-17 | -12.00 |
| 2024-10-16 | -12.23 |
| 2024-10-15 | -11.61 |
| 2024-10-14 | -11.51 |
| 2024-10-11 | -11.63 |
| 2024-10-10 | -11.25 |
| 2024-10-09 | -11.06 |
| 2024-10-08 | -11.45 |
| 2024-10-07 | -10.95 |
| 2024-10-04 | -11.26 |
| 2024-10-03 | -11.59 |
| 2024-10-02 | -12.28 |
| 2024-10-01 | -12.01 |
| 2024-09-30 | -12.41 |
| 2024-09-27 | -11.69 |
| 2024-09-26 | -11.96 |
| 2024-09-25 | -12.05 |
| 2024-09-24 | -11.54 |
| 2024-09-23 | -11.97 |
| 2024-09-20 | -12.64 |